EDITION OF THU 24 SEP 2026
57 · BUSINESS

FDA Elevates Thyroid Medication Recall to Highest Risk Level

publishers 5articles 5first reported 24 Sep, 12:18 UTCdeveloping since 24 Sep · 6 editions

The Food and Drug Administration has elevated a recall of thyroid medication tablets to its highest risk level. Health.com reported that the recalled drug may be “superpotent.”

HOW THIS STORY WAS MADE

Written from 5 articles, headlines and summaries only; 5 independent newsrooms once syndicated copies count as one (4 if wire copies count as one too); the editor kept it as written.

Publishers
5
Source articles
5
Given to the writer
5, headlines and summaries only
Independent newsrooms
5 (4 if wire copies count as one)
Second model (editor)
kept as written
Publication gate
passed
Human review
none

Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →

NAMED IN THE COVERAGE

OUTLETS CARRYING THE STORY, RUN BY RUN

0 8 17 25 Sep 26 Sep 27 Sep 28 Sep 29 Sep 25 Sep 00:18 UTC · FDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled

WHAT HELD, WHAT CAME LATER

From the first reports to the latest

  • Nothing ran from the first third of the coverage to the last.

Entered the story later

  • Nothing new took hold after the first third.

HOW THIS STORY DEVELOPED: EVERY HEADLINE, EVERY OUTLET →